BAM
GRNA

Belpointe Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Belpointe Asset Management’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,500
Closed -$1.08K – 3670
2023
Q1 		$1.08K Hold
2,500
– – ﹤0.01% 3457
2022
Q4 		$2.95K Buy
+2,500
New +$2.95K ﹤0.01% 3126